Population pharmacokinetics of CPT-11 (irinotecan) in gastric cancer patients with peritoneal seeding after its intraperitoneal administration

被引：0

作者：

Byung-Jin Ahn

Moon Ki Choi

Young Suk Park

Jeeyun Lee

Se Hoon Park

Joon Oh Park

Ho Yeong Lim

Won Ki Kang

Jae-Wook Ko

Dong-Seok Yim

机构：

[1] Dongguk University,Medical Science Research Center

[2] Sungkyunkwan University School of Medicine,Division of Hematology

[3] Samsung Medical Center,Oncology, Department of Medicine, Samsung Medical Center

[4] The Catholic University of Korea,Department of Clinical Pharmacology & Therapeutics

来源：

European Journal of Clinical Pharmacology | 2010年 / 66卷

关键词：

Gastric cancer; CPT-11; Intraperitoneal administration; Pharmacokinetics; NONMEM;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1235 / 1245

页数：10

共 50 条

[1] Population pharmacokinetics of CPT-11 (irinotecan) in gastric cancer patients with peritoneal seeding after its intraperitoneal administration
Ahn, Byung-Jin
Choi, Moon Ki
Park, Young Suk
Lee, Jeeyun
Park, Se Hoon
Park, Joon Oh
Lim, Ho Yeong
Kang, Won Ki
Ko, Jae-Wook
Yim, Dong-Seok
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (12) : 1235 - 1245
[2] POPULATION PHARMACOKINETICS OF CPT-11 ( IRINOTECAN) IN GASTRIC CANCER PATIENTS WITH PERITONEAL METASTASIS AFTER INTRAPERITONEAL ADMINISTRATION.
Ahn, B.
Choi, M.
Park, Y.
Lee, J.
Park, S.
Park, J.
Lim, H.
Kang, W.
Heo, J.
Ko, J.
Lee, J.
Yim, D.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S87 - S87
[3] Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis
Maruyama, M
Nagahama, T
Yuasa, Y
ANTICANCER RESEARCH, 1999, 19 (5B) : 4187 - 4191
[4] Irinotecan (CPT-11) metabolism and disposition in cancer patients
Sparreboom, A
de Jonge, MJA
de Bruijn, P
Brouwer, E
Nooter, K
Loos, WJ
van Alphen, RJ
Mathijssen, RHJ
Stoter, G
Verweij, J
CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2747 - 2754
[5] Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following i.v. infusion of [14C]CPT-11 in cancer patients
Slatter, JG
Schaaf, LJ
Sams, JP
Feenstra, KL
Johnson, MG
Bombardt, PA
Cathcart, KS
Verburg, MT
Pearson, LK
Compton, LD
Miller, LL
Baker, DS
Pesheck, CV
Lord, RS
DRUG METABOLISM AND DISPOSITION, 2000, 28 (04) : 423 - 433
[6] Irinotecan Hydrochloride (CPT-11) in Dialysis Patients with Gastrointestinal Cancer
Ashizawa, Tatsuto
Iwahori, Tohru
Yokoyama, Takayoshi
Kihara, Yuu
Konnno, Osamu
Jyojima, Yoshimaro
Akashi, Isao
Nakamura, Yuuki
Hama, Kouichirou
Iwamoto, Hitoshi
Segawa, Mai
Takeuchi, Hironori
Hirano, Toshihiko
Nagao, Takeshi
ACTA MEDICA OKAYAMA, 2010, 64 (01) : 19 - 26
[7] SIMULTANEOUS ADMINISTRATION OF CPT-11 AND FLUOROURACIL - ALTERATION OF THE PHARMACOKINETICS OF CPT-11 AND SN-38 IN PATIENTS WITH ADVANCED COLORECTAL-CANCER
SASAKI, Y
OHTSU, A
SHIMADA, Y
ONO, K
SAIJO, N
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (14) : 1096 - 1098
[8] Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma
Younis, Islam R.
Malone, Samuel
Friedman, Henry S.
Schaaf, Larry J.
Petros, William P.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 517 - 524
[9] Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma
Islam R. Younis
Samuel Malone
Henry S. Friedman
Larry J. Schaaf
William P. Petros
Cancer Chemotherapy and Pharmacology, 2009, 63 : 517 - 524
[10] Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding
Moon Ki Choi
Byung-Jin Ahn
Dong-Seok Yim
Young Suk Park
Sung Kim
Tae Sung Sohn
Jae Hyung Noh
Jin Seok Heo
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Ho Yeong Lim
Won Ki Kang
Cancer Chemotherapy and Pharmacology, 2011, 67 : 5 - 11

← 1 2 3 4 5 →